Nemaura Medical Inc.
NMRDDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001602078
Nemaura Medical Inc. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Jan 9, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $280.9K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Nemaura Medical Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +7 vs. Q2 2023
- Shares held
- 2.22M
- −605.4K (−21.5%) vs. Q2 2023
- Total value
- $698.6K
- −$1.91M (−73.2%) vs. Q2 2023
- New holders
- 7
- 2 more added
- Sold out
- 0
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 2 | $1.85K |
| Q4 2023 | 21 | $280.9K |
| Q3 2023 | 22 | $698.6K |
| Q2 2023 | 15 | $2.61M |
| Q1 2023 | 16 | $2.88M |
| Q4 2022 | 16 | $1.39M |
| Q3 2022 | 20 | $1.71M |
| Q2 2022 | 19 | $2.16M |
| Q1 2022 | 17 | $3.70M |
| Q4 2021 | 17 | $2.29M |
| Q3 2021 | 17 | $3.62M |
| Q2 2021 | 29 | $10.8M |
| Q1 2021 | 30 | $8.29M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Nemaura Medical Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hazlett, Burt & Watson, Inc. | 30 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 268 | $0 | 0.00% | −164−38.0% | Reduced |
| Simplex Trading, LLC | 2,814 | $0 | 0.00% | +2,814 | New |
| Ronald Blue Trust, Inc. | 500 | $0 | 0.00% | +500 | New |
| Salomon & Ludwin, LLC | 3 | $1 | 0.00% | +3 | New |
| Qube Research & Technologies Ltd | 8 | $3 | 0.00% | +8 | New |
| JPMorgan Chase & Co | 12 | $4 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 85 | $27 | 0.00% | −85−50.0% | Reduced |
| Morgan Stanley | 100 | $32 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 360 | $113 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 500 | $158 | 0.00% | +500 | New |
| Federation des caisses Desjardins du Quebec | 1,950 | $614 | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 3,542 | $1.12K | 0.00% | −1,101−23.7% | Reduced |
| Wells Fargo & Company | 4,158 | $1.31K | 0.00% | +20.0% | Added |
| Tower Research Capital LLC (TRC) | 11,940 | $3.76K | 0.00% | +4,612+62.9% | Added |
| Virtu Financial LLC | 12,213 | $4.00K | 0.00% | +12,213 | New |
| Susquehanna International Group, LLP | 20,230 | $6.53K | 0.00% | +20,230 | New |
| Northern Trust Corp | 26,737 | $8.42K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 53,666 | $17.3K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 107,897 | $34.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 126,682 | $39.9K | 0.00% | −4,179−3.2% | Reduced |
| Alyeska Investment Group, L.P. | 1,842,565 | $580.4K | 0.00% | −640,706−25.8% | Reduced |